UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korean pharma’s Q1 performance not affected by Covid-19
Despite the global spread of the new coronavirus, the local pharmaceutical ...
by Kim Yun-mi
|
2020-05-22 17:29
라인
Chinese regulator OKs Genexine's P2 trial of glioblastoma treatment
Genexine said that China's National Medical Products Administration has...
by Lee Han-soo
|
2020-05-22 17:23
라인
JW Pharma launches long-lasting hydraulic acid filler
JW Pharmaceutical said that it has launched Hyalanse, a long-lasting hyalur...
by Lee Han-soo
|
2020-05-22 16:20
라인
‘No reckless interpretations of Moderna’s Covid-19 vaccine results’
An infectious disease expert cautioned against the hasty interpretation of ...
by Kim Yun-mi
|
2020-05-22 15:27
라인
Alvogen’s obesity drug threatens Novo Nordisk's stronghold in Korea
Novo Nordisk’s Saxenda is facing fierce competition to keep its dominance i...
by Lee Han-soo
|
2020-05-22 15:19
라인
Despite efforts to stem cluster infections, sporadic outbreaks continue
Korea reported 20 new coronavirus cases Friday amid efforts to prevent furt...
by Shim Hyun-tai
|
2020-05-22 12:36
라인
St. Mary’s Hospital keeps treating severe blood diseases even amid Covid-19
St. Mary's Hospital, which had kept treating people suffering from hemo...
by Shim Hyun-tai
|
2020-05-21 18:10
라인
New endoscopic surgical way found to reduce pancreatitis incidence
An Inha University Hospital research team has released a paper that primary...
by Shim Hyun-tai
|
2020-05-21 17:37
라인
KMA to ask 27 countries to recognize Korean medical license
The Korean Medical Association said it would request 27 countries to allow ...
by Choi Gwang-seok
|
2020-05-21 17:10
라인
‘Too early to call Korea’s Covid-19 control success’
An infectious disease expert warned that it would be too early to conclude ...
by Choi Gwang-seok
|
2020-05-21 17:08
라인
Alvogen Korea to market Luye Pharma’s schizophrenia treatment
Alvogen Korea said that it would exclusively supply and market Luye Pharma ...
by Lee Han-soo
|
2020-05-21 17:02
라인
National Cancer Center confirms efficacy of proton treatment
The National Cancer Center has published clinical research findings, which ...
by Lee Han-soo
|
2020-05-21 17:02
라인
Regulators OKs Macrogen’s export of Covid-19 diagnostic kits
Macrogen said Thursday that it has obtained approval to export AxenTM COVID...
by Lee Han-soo
|
2020-05-21 17:02
라인
Korea’s daily virus curve seesaws amid lingering cluster infections
New virus cases fell back to around 10 as of midnight Wednesday from a 10-d...
by Shim Hyun-tai
|
2020-05-21 14:11
라인
Lunit, Yongin Severance Hospital to research AI-based medical technologies
Lunit said that it has agreed with Yongin Severance Hospital to conduct fur...
by Lee Han-soo
|
2020-05-21 12:34
라인
[Exclusive] Thailand recalls Medytox’s botulinum toxin
The Thai government not only suspended the sale of Meditoxin, a botulinum t...
by Jeong Sae-im
|
2020-05-21 12:33
라인
School reopening makes a squeaky start due to virus cases
High schools in Korea started offline classes for senior students after 80 ...
by Shim Hyun-tai
|
2020-05-20 18:32
라인
SK’s offshoot picked as major raw material supplier to US
SK Holdings said Wednesday its active drug ingredient maker, AMPAC Fine Che...
by Shim Hyun-tai
|
2020-05-20 18:32
라인
Humasis to donate Covid-19 test kits to Myanmar
Humasis, a multi-quantitative in vitro diagnostic company, will provide the...
by Shim Hyun-tai
|
2020-05-20 18:31
라인
Eisai Korea expands indication for epilepsy treatment
Eisai Korea said that it has received an expanded indication for Fycompa, a...
by Lee Han-soo
|
2020-05-20 17:11
-
이전
31
32
33
34
35
36
37
38
39
40
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top